AMYT

AMRYT PHARMA PLC ORD 6P

TitleTime
Q1 2020 RESULTSMon 11/05/20 | 07:00
FY 2019 RESULTSMon 11/05/20 | 07:00
Notice of ResultsThu 07/05/20 | 09:00
FILSUVEZ® CONFIRMED AS GLOBAL BRAND NAME FOR AP101Thu 07/05/20 | 07:00
EASE CLINICAL STUDY UPDATEThu 23/04/20 | 07:00
Holding(s) in CompanyWed 25/03/20 | 07:00
Market UpdateMon 23/03/20 | 07:00
Draft registration statement for US Nasdaq listingWed 19/02/20 | 12:00
Holding(s) in CompanyWed 15/01/20 | 17:16
Amryt to present updates from its EB researchWed 15/01/20 | 07:00
PDMR DealingsTue 07/01/20 | 12:09
Holding(s) in CompanyMon 30/12/19 | 11:07
Euronext Growth Dublin NoticeFri 27/12/19 | 08:00
Holding(s) in CompanyMon 23/12/19 | 11:22
Exercise of Warrants & Issue of Ordinary SharesFri 20/12/19 | 14:40
Business integration and synergies on trackThu 19/12/19 | 07:00
Holdings in CompanyTue 26/11/19 | 07:00
Holdings in CompanyMon 18/11/19 | 07:00
Share BuybackThu 14/11/19 | 16:31
Grant of OptionsTue 05/11/19 | 18:16
Trading UpdateTue 05/11/19 | 07:00
Notice of Trading UpdateMon 04/11/19 | 07:00
Holding(s) in CompanyMon 28/10/19 | 16:58
Holdings in CompanyThu 03/10/19 | 16:38
AP101 Receives Fast Track Designation from FDATue 01/10/19 | 07:00
Half-year ReportMon 30/09/19 | 16:30
Holding(s) in CompanyMon 30/09/19 | 07:00
Completion of Acquisition and $60m equity raisedWed 25/09/19 | 07:00
Schedule One Update - Amryt Pharma PlcTue 24/09/19 | 12:30
Schedule One UpdateTue 24/09/19 | 08:29
Suspension - Amryt Pharma PlcTue 24/09/19 | 07:30
Court Sanction of the Scheme of ArrangementMon 23/09/19 | 14:15
Euronext Growth Dublin NoticeFri 20/09/19 | 08:00
Results of Court Meeting and General MeetingThu 19/09/19 | 13:30
Circular to ShareholdersFri 13/09/19 | 07:00
Update on Acquisition of AegerionWed 11/09/19 | 15:00
Schedule OneThu 05/09/19 | 14:30
Schedule One - Amryt Pharma plcThu 05/09/19 | 14:30
Euronext Growth Dublin Suspension NoticeWed 04/09/19 | 08:00
Suspension of Trading on EuronextWed 04/09/19 | 07:00
Holdings in CompanyTue 03/09/19 | 13:00
Holding(s) in CompanyFri 30/08/19 | 15:06
Euronext Growth Dublin NoticeFri 30/08/19 | 08:00
Director/PDMR ShareholdingFri 30/08/19 | 07:00
Publication of Admission Document and CircularTue 27/08/19 | 13:00
Restoration - Amryt Pharma PlcTue 27/08/19 | 13:00
Euronext Growth Dublin Restoration NoticeTue 27/08/19 | 13:00
Result of AGMWed 10/07/19 | 11:23
Posting of Annual Report and Notice of AGMWed 12/06/19 | 07:00
Grant of OptionsWed 22/05/19 | 18:24
Suspension - Amryt Pharma plcTue 21/05/19 | 07:30
Euronext Growth Dublin Suspension NoticeTue 21/05/19 | 07:30
Recommended Acquisition of AegerionTue 21/05/19 | 07:00
Preliminary Results and Q1 Trading UpdateWed 17/04/19 | 07:00
Notice of ResultsFri 12/04/19 | 10:04
Update on AP101 EASE Phase III trialThu 28/02/19 | 07:00
Positive results for gene therapy AP103Mon 07/01/19 | 07:00
EASE Phase III trial interim efficacy resultsFri 04/01/19 | 12:56
Second Price Monitoring ExtnFri 21/12/18 | 14:05
Price Monitoring ExtensionFri 21/12/18 | 14:00
Update on ongoing AP101 TrialWed 19/12/18 | 07:00
Grant Funding from Irish Government for AP103Mon 10/12/18 | 11:30
Lojuxta to be reimbursed in FranceWed 17/10/18 | 07:00
Interim ResultsWed 26/09/18 | 07:00
Notice of ResultsFri 14/09/18 | 07:00
Amryt receives IND approval from FDA for AP101Mon 10/09/18 | 07:00
FDA grants Pediatric Rare Disease designationThu 02/08/18 | 07:00
Trading update & significant momentum buildingThu 19/07/18 | 07:00
NHS England approves funding for LojuxtaMon 09/07/18 | 07:00
Change of Registered AddressFri 06/07/18 | 07:00
Result of AGMTue 05/06/18 | 10:41
Exclusive Lojuxta® Licence ExpandedThu 10/05/18 | 07:00
Holding(s) in CompanyWed 09/05/18 | 14:48
Holding(s) in Company and Lock-in agreementTue 08/05/18 | 07:00
Posting of Annual Report 2017 and Notice of AGMFri 04/05/18 | 07:00
Final ResultsTue 17/04/18 | 07:00
Trading update & Gene therapy agreementThu 15/03/18 | 07:00
Distribution Agreement for Lojuxta in Middle EastTue 06/03/18 | 07:00
Notice of Trading UpdateFri 02/03/18 | 07:00
New Distribution Agreement SignedTue 30/01/18 | 07:00
New Distribution Agreement SignedWed 10/01/18 | 07:00
Distribution Agreement Signed Covering SwitzerlandMon 08/01/18 | 07:00
Grant of Options & PDMR DealingsFri 01/12/17 | 07:00
Price Monitoring ExtensionMon 20/11/17 | 16:35
Distribution Agreement Signed in Saudi ArabiaMon 13/11/17 | 07:00
Holding(s) in CompanyFri 13/10/17 | 15:29
Holding(s) in CompanyWed 11/10/17 | 07:00
Director Share PurchasesWed 11/10/17 | 07:00
Enterprise Securities Market NoticeWed 11/10/17 | 07:00
Enterprise Securities Market NoticeTue 10/10/17 | 07:00
Result of General Meeting & Completion of PlacingMon 09/10/17 | 12:13
Placing to raise EUR 15mThu 21/09/17 | 07:00
Interim ResultsMon 04/09/17 | 07:00
Notice of ResultsWed 23/08/17 | 08:30